How Data Gaps Impact COVID-19 Vaccine Hesitancy
This opinion piece was authored by Dr. Michelle Fiscus, a subject matter expert that consults for AIM. Note: this opinion piece is not an official AIM statement.
How Valuing the Public Health Workforce Impacts COVID-19 Vaccine Hesitancy
This opinion piece was authored by Dr. Michelle Fiscus, a subject matter expert that consults for AIM. Note: this opinion piece is not an official AIM statement.
Supporting Immunization Programs to Address COVID-19 Vaccine Hesitancy: Recommendations for National and Community-Based Stakeholders
In collaboration with Immunize.org and Emory University, AIM’s Chief Research and Development Officer, Katelyn Wells, Ph.D., published an article in Vaccine.
AIM Awards Now Open! 2022 Leadership in Action Conference
AIM is excited to announce that it will resume the annual presentation of awards at our in-person conference in Philadelphia.
AIM Receives the 2022 Distinguished Service Award from the National Association of School Nurses
AIM is honored to receive the 2022 Distinguished Service Award from the National Association of School Nurses (NASN).
AIM Champion Award 2022 Announcement
The 2022 AIM Champion Award is kicking off soon! AIM is excited to recognize individuals contributing to public health through their immunizations roles.
AIM and HRSA Project Announcement: Community Health Workers
AIM is thrilled to support the Center for Global Health Innovation Vaccine Access and Training (VAT) project.
State Strategies to Increase COVID-19 Vaccination Rates in Children Blog Post
Dr. Shelley Fiscus and Rebecca Cooper have published a new blog titled “State Strategies to Increase COVID-19 Vaccination Rates in Children.”
Updated Hepatitis B Vaccination Recommendation
The updated Hep B recommendation expands the vaccination age range and removes the risk factor assessment for determining vaccine eligibility.
New AIM Issue Brief: Potential Impact on Vaccine Policy by Ending the Federal Public Health Emergency Declarations
This new AIM issue brief discusses the impact of the end of emergency declaration, including the end of the PREP act and federal authority for pharmacists to vaccinate, FEMA reimbursement for their COVID vaccination efforts, and certain Medicaid eligibility.